The Discovery of Novel Human Androgen Receptor Antagonist Chemotypes Using a Combined Pharmacophore Screening Procedure

New developments in castrate-resistant prostate cancer

(2012) N. Shore et al.   BJU INTERNATIONAL

Androgen receptor antagonists: a patent review (2008 – 2011)

(2012) Michael L Mohler et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

A role for selective androgen response elements in the development of the epididymis and the androgen control of the 5α reductase II gene

(2012) Stefanie Kerkhofs et al.   FASEB JOURNAL

Identification and Characterization of MEL-3, a Novel AR Antagonist That Suppresses Prostate Cancer Cell Growth

(2012) Christine Helsen et al.   MOLECULAR CANCER THERAPEUTICS

In SilicoDiscovery of Androgen Receptor Antagonists with Activity in Castration Resistant Prostate Cancer

(2012) Howard C. Shen et al.   MOLECULAR ENDOCRINOLOGY

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

(2012) Howard I. Scher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Novel agents and new therapeutics in castration-resistant prostate cancer

(2011) Yichao Wu et al.   CURRENT OPINION IN ONCOLOGY

DSX: A Knowledge-Based Scoring Function for the Assessment of Protein–Ligand Complexes

(2011) Gerd Neudert et al.   Journal of Chemical Information and Modeling

New Strategies for Medical Management of Castration-Resistant Prostate Cancer

(2011) Irène Asmane et al.   ONCOLOGY

Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database

(2010) Paul C. D. Hawkins et al.   Journal of Chemical Information and Modeling

Androgen receptor amplification is reflected in the transcriptional responses of Vertebral-Cancer of the Prostate cells

(2010) Harri Makkonen et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

The Rules of DNA Recognition by the Androgen Receptor

(2010) Sarah Denayer et al.   MOLECULAR ENDOCRINOLOGY

Castration-Resistant Prostate Cancer: Locking Up the Molecular Escape Routes

(2009) R. M. Attar et al.   CLINICAL CANCER RESEARCH

Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer

(2009) C. Tran et al.   SCIENCE